A company developing an experimental vaccine for the coronavirus says early data shows encouraging results. Massachusetts-based Moderna Inc. said Monday that the vaccine triggered immune responses in healthy middle-aged volunteers. The company said the volunteers also had antibodies similar to people who had recovered from COVID-19. The vaccine now goes to the next phase of research where scientists will try to determine which dose is best for another experiment they plan to start in July. There are about a dozen vaccine candidates in development worldwide. Government officials said on Friday they hope to have a vaccine available for hundreds of millions of Americans by the end of this year.
Here’s what else you need to know about COVID-19 around the world:
• There have been more than 1.4 million coronavirus cases in the United States and more than 89,000 deaths.
• New York City is ramping up its ability to test, with testing available at more than 150 sites citywide and test kits made in the city now in use at city-run health clinics.
• In separate stark warnings, Italian Premier Giuseppe Conte and British Prime Minister Boris Johnson bluntly told their citizens that the world needs to adapt to living with the coronavirus and cannot wait to be saved by a vaccine. |
